Durham's Argos borrows $25M to work on cancer drug

Durham drug developer Argos Therapeutics, Inc. borrowed $25 million in a round led by Horizon Technology Finance Corporation through a venture loan...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.